An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
NCT01488331
·
clinicaltrials.gov ↗
COMPLETED
Status
217
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Squamous Non-Small Cell Lung Cancer
Sponsor
Hoffmann-La Roche